Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Epstein-Barr Virus
100%
Older Adults
100%
Leiomyosarcoma
100%
Hodgkin Lymphoma
100%
Concurrent Occurrence
100%
Tumor
50%
Smooth muscle Tumor
50%
Tumor Cells
33%
Epstein-Barr Virus-encoded RNA
33%
Dural-based
33%
Frontal Lobe
16%
CD34
16%
S100 Proteins
16%
Malignancy
16%
Older Men
16%
Differential Diagnosis
16%
Adult Patients
16%
Pediatric Patients
16%
α-smooth muscle Actin (α-SMA)
16%
Clinical History
16%
HIV-negative
16%
Brain Lesions
16%
Edema
16%
B-cell Lymphoma 2 (Bcl-2)
16%
Epstein-Barr Virus Infections
16%
Falx
16%
Reed-Sternberg Cells
16%
Ki-67 Index
16%
Fascicle
16%
Gross Total Resection
16%
Necrosis
16%
Cellular Immunity
16%
Desmin
16%
Spindle Cell
16%
RNA Fluorescence in Situ Hybridization (RNA-FISH)
16%
Laboratory Data
16%
Spindle Cell Neoplasm
16%
Immunocompetent Adult
16%
Caldesmon
16%
CD99
16%
Mitotic Activity
16%
Immunocompetence
16%
Heterogeneous Groups
16%
Recently Diagnosed
16%
Cell Staining
16%
History Data
16%
Multi-focus
16%
Routine Laboratory
16%
Enhancing Tumor
16%
Prefrontal Lobotomy
16%
Medicine and Dentistry
Epstein Barr Virus
100%
Hodgkin's Lymphoma
100%
Leiomyosarcoma
100%
Neoplasm
83%
Angioleiomyoma
50%
Tumor Cell
33%
Spindle Cell
33%
Cancer
16%
S-100 Protein
16%
Polyethylene Terephthalate
16%
Magnetic Resonance Imaging
16%
Differential Diagnosis
16%
Mitosis Rate
16%
In Situ Hybridization
16%
Necrosis
16%
Human immunodeficiency virus
16%
Pediatrics Patient
16%
Smooth Muscle Actin
16%
Edema
16%
Epstein-Barr Virus Infection
16%
Lobectomy
16%
Reed-Sternberg Cell
16%
Desmin
16%
Cellular Immunity
16%
Caldesmon
16%
Frontal Lobe
16%
Immunocompetence
16%